Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 9.80
+0.05 (0.51%)
Jul 27, 2026, 4:27 PM GMT
Abingdon Health Financials Overview
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 9.57 | 8.43 | 6.14 | 4.05 | 2.84 | 11.62 |
Revenue Growth | 13.56% | 37.39% | 51.67% | 42.68% | -75.60% | 121.93% |
Gross Profit Gross Profit Growth | 3.96 | 3.74 | 3.68 | 2.08 | -3.59 | 4.14 |
Operating Income Operating Income Growth | -3.15 | -3.51 | -1.37 | -3.59 | -21.53 | -6.72 |
Net Income Net Income Growth | -3.24 | -3.42 | -1.27 | -3.47 | -21.26 | -6.97 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 | -0.03 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Product Sales Product Sales Growth | 0.42 | 0.53 | 0.65 | 0.42 | 0.47 | 8.36 |
Contract Manufacturing Contract Manufacturing Growth | 1.23 | 1.27 | 1.26 | 1.06 | 1.12 | 1.69 |
Regulatory Regulatory Growth | 4.04 | 3.42 | 0.9 | 0.27 | - | - |
Contract Development Contract Development Growth | - | 3.21 | 3.33 | 2.3 | 1.25 | 1.57 |
Total Total Growth | 9.57 | 8.43 | 6.14 | 4.05 | 2.84 | 11.62 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 3.71 | 1.92 | 1.44 | 3.24 | 2.4 | 4.98 |
Total Debt Total Debt Growth | 0.95 | 1.03 | 1.05 | 1.02 | 1.28 | 1.5 |
Net Cash (Debt) Net Cash Growth | 2.76 | 0.89 | 0.39 | 2.22 | 1.12 | 3.48 |
Net Cash Growth | 210.00% | 127.62% | -82.36% | 98.48% | -67.92% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2.27 | -3.18 | -1.66 | 0.91 | -7.74 | -12.88 |
Capital Expenditures CapEx Growth | -0.35 | -0.33 | -0.04 | -0.08 | -0.68 | -6.76 |
Free Cash Flow Free Cash Flow Growth | -2.62 | -3.51 | -1.69 | 0.84 | -8.42 | -19.64 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 41.38% | 44.32% | 59.97% | 51.30% | -126.70% | 35.66% |
Operating Margin | -32.92% | -41.63% | -22.38% | -88.70% | -759.37% | -57.84% |
Pretax Margin | -33.02% | -41.48% | -22.80% | -88.36% | -761.66% | -59.86% |
Profit Margin | -33.88% | -40.51% | -20.72% | -85.76% | -749.98% | -60.02% |
FCF Margin | -27.36% | -41.63% | -27.61% | 20.72% | -297.04% | -169.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
P/FCF Ratio | - | - | - | 43.54 | - | - |
PS Ratio | 4.48 | 1.61 | 2.12 | 9.02 | 4.72 | 4.02 |